These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10619226)

  • 1. Haloperidol, midazolam and intravenous sedation.
    Ryan CJ
    Aust N Z J Psychiatry; 1999 Dec; 33(6):942-3. PubMed ID: 10619226
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'cardiotoxicity associated with use of intravenous haloperidol'.
    Aust N Z J Psychiatry; 1999 Dec; 33(6):943-4. PubMed ID: 10619227
    [No Abstract]   [Full Text] [Related]  

  • 3. Torsade de pointes associated with the administration of intravenous haloperidol.
    Hassaballa HA; Balk RA
    Am J Ther; 2003; 10(1):58-60. PubMed ID: 12522522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsade de pointes and low-dose oral haloperidol.
    Jackson T; Ditmanson L; Phibbs B
    Arch Intern Med; 1997 Sep; 157(17):2013-5. PubMed ID: 9308514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
    Baldaçara L; Sanches M; Cordeiro DC; Jackoswski AP
    Braz J Psychiatry; 2011 Mar; 33(1):30-9. PubMed ID: 21537720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.
    Hassaballa HA; Balk RA
    Expert Opin Drug Saf; 2003 Nov; 2(6):543-7. PubMed ID: 14585064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review.
    Hunt N; Stern TA
    Psychosomatics; 1995; 36(6):541-9. PubMed ID: 7501784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?
    Meyer-Massetti C; Cheng CM; Sharpe BA; Meier CR; Guglielmo BJ
    J Hosp Med; 2010 Apr; 5(4):E8-16. PubMed ID: 20394022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of the concept of relative potency: an example involving chlorpromazine and haloperidol.
    Preskorn SH
    J Psychiatr Pract; 2005 Jul; 11(4):258-61. PubMed ID: 16041236
    [No Abstract]   [Full Text] [Related]  

  • 10. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery.
    Perrault LP; Denault AY; Carrier M; Cartier R; Bélisle S
    Can J Anaesth; 2000 Mar; 47(3):251-4. PubMed ID: 10730737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsafe use of intravenous haloperidol: evaluation of recommendation-concordant care in hospitalized elderly adults.
    Cheung D; Wolfe B; Wald H; Cumbler E
    J Am Geriatr Soc; 2013 Jan; 61(1):160-1. PubMed ID: 23311558
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill.
    Metzger E; Friedman R
    J Clin Psychopharmacol; 1993 Apr; 13(2):128-32. PubMed ID: 8463445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular risk of haloperidol vs. atypical anti-psychotic drugs in schizophrenia treatment].
    Dobrin I; Dobrin RP; Chele G; Stefănescu C; Knieling A; Chiriţă R
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):658-61. PubMed ID: 21243790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol-induced ileus.
    Sirois FJ
    Psychosomatics; 2005; 46(3):275-6. PubMed ID: 15883151
    [No Abstract]   [Full Text] [Related]  

  • 15. A computerized physician order entry set designed to improve safety of intravenous haloperidol utilization: a retrospective study in agitated hospitalized patients.
    Muzyk AJ; Rivelli SK; Jiang W; Heinz H; Rayfield A; Gagliardi JP
    Drug Saf; 2012 Sep; 35(9):725-31. PubMed ID: 22876752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsades de Pointes associated with intravenous haloperidol in critically ill patients.
    Sharma ND; Rosman HS; Padhi ID; Tisdale JE
    Am J Cardiol; 1998 Jan; 81(2):238-40. PubMed ID: 9591913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol-induced torsade de pointes.
    O'Brien JM; Rockwood RP; Suh KI
    Ann Pharmacother; 1999 Oct; 33(10):1046-50. PubMed ID: 10534216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Administration of high dose haloperidol in a patient refractory to treatment with traditional and atypical neuroleptics].
    Stip E; Bruneau MA
    Encephale; 1996; 22(4):298-300. PubMed ID: 9035986
    [No Abstract]   [Full Text] [Related]  

  • 19. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
    Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
    Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Premedication with midazolam in adults with special reference to anxiety treatment].
    Röse VW
    Anaesthesiol Reanim; 1996; 21(1):14-23. PubMed ID: 8901180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.